Vera Therapeutics Statistics Share Statistics Vera Therapeutics has 63.82M
shares outstanding. The number of shares has increased by 0.79%
in one year.
Shares Outstanding 63.82M Shares Change (YoY) 0.79% Shares Change (QoQ) 0.08% Owned by Institutions (%) 94.69% Shares Floating 44.83M Failed to Deliver (FTD) Shares 18,588 FTD / Avg. Volume 1.12%
Short Selling Information The latest short interest is 9.36M, so 14.68% of the outstanding
shares have been sold short.
Short Interest 9.36M Short % of Shares Out 14.68% Short % of Float 16.91% Short Ratio (days to cover) 5.1
Valuation Ratios The PE ratio is -15.38 and the forward
PE ratio is -6.36.
Vera Therapeutics's PEG ratio is
-0.69.
PE Ratio -15.38 Forward PE -6.36 PS Ratio 0 Forward PS 54.5 PB Ratio 4.05 P/FCF Ratio -17.25 PEG Ratio -0.69
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vera Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 25.67,
with a Debt / Equity ratio of 0.09.
Current Ratio 25.67 Quick Ratio 25.67 Debt / Equity 0.09 Debt / EBITDA -0.33 Debt / FCF -0.4 Interest Coverage -21.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1M Employee Count 152 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -26.2% in the
last 52 weeks. The beta is 1.23, so Vera Therapeutics's
price volatility has been higher than the market average.
Beta 1.23 52-Week Price Change -26.2% 50-Day Moving Average 23.44 200-Day Moving Average 26.78 Relative Strength Index (RSI) 75.79 Average Volume (20 Days) 1,655,381
Income Statement
Revenue n/a Gross Profit n/a Operating Income -167.17M Net Income -152.15M EBITDA -167.17M EBIT -159.77M Earnings Per Share (EPS) -2.75
Full Income Statement Balance Sheet The company has 92.65M in cash and 54.64M in
debt, giving a net cash position of 38.01M.
Cash & Cash Equivalents 92.65M Total Debt 54.64M Net Cash 38.01M Retained Earnings -461.25M Total Assets 578.53M Working Capital 534.1M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -134.68M
and capital expenditures -972K, giving a free cash flow of -135.65M.
Operating Cash Flow -134.68M Capital Expenditures -972K Free Cash Flow -135.65M FCF Per Share -2.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
